HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polymorphisms of RANTES and IL-4 genes in cerebral infarction.

Abstract
Chemoattractant peptides (chemokines) and cytokines have been shown to play a key role in the inflammatory development and progression of cerebrovascular disease. The effect of polymorphisms in regulated upon activation, normal T cells expressed, and secreted (RANTES) and interleukin-4 (IL-4) genes on cerebral infarction (CI) is evaluated in this study. Patients with CI (n = 320) and healthy controls (n = 481) were genotyped for RANTES-403 and IL-4 variable number of tandem repeat (VNTR) polymorphisms using polymerase chain reaction (PCR) or PCR-restriction fragment length polymorphism. A significant difference was observed between the CI group and controls in subjects with the RANTES AA genotype in IL-4 A3- carriers (18.6% vs. 13.1%, P = 0.035, odds ratio = 1.5, 95% confidence interval = 1.03-2.25). These findings suggest that the RANTES G-403A allele increased the relative risk for CI in the subjects without the IL-4 VNTR allele 3.
AuthorsJae-Young Um, Hyung-Min Kim
JournalJournal of molecular neuroscience : MN (J Mol Neurosci) Vol. 37 Issue 1 Pg. 1-5 (Jan 2009) ISSN: 0895-8696 [Print] United States
PMID18696265 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CCL5 protein, human
  • Chemokine CCL5
  • IL4 protein, human
  • Interleukin-4
Topics
  • Asian People (genetics, statistics & numerical data)
  • Cerebral Infarction (ethnology, genetics)
  • Chemokine CCL5 (genetics)
  • Genetic Predisposition to Disease (ethnology)
  • Genotype
  • Humans
  • Interleukin-4 (genetics)
  • Korea (epidemiology)
  • Polymorphism, Genetic
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: